206 related articles for article (PubMed ID: 23567489)
1. Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.
Stevens A; Clayton P; Tatò L; Yoo HW; Rodriguez-Arnao MD; Skorodok J; Ambler GR; Zignani M; Zieschang J; Della Corte G; Destenaves B; Champigneulle A; Raelson J; Chatelain P
Pharmacogenomics J; 2014 Feb; 14(1):54-62. PubMed ID: 23567489
[TBL] [Abstract][Full Text] [Related]
2. A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome.
Clayton P; Chatelain P; Tatò L; Yoo HW; Ambler GR; Belgorosky A; Quinteiro S; Deal C; Stevens A; Raelson J; Croteau P; Destenaves B; Olivier C
Eur J Endocrinol; 2013 Sep; 169(3):277-89. PubMed ID: 23761422
[TBL] [Abstract][Full Text] [Related]
3. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
4. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
[TBL] [Abstract][Full Text] [Related]
5. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
Cutfield WS; Lundgren F
Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
[TBL] [Abstract][Full Text] [Related]
7. IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance.
Das U; Whatmore AJ; Khosravi J; Wales JK; Butler G; Kibirige MS; Diamandi A; Jones J; Patel L; Hall CM; Price DA; Clayton PE
Eur J Endocrinol; 2003 Sep; 149(3):179-85. PubMed ID: 12943519
[TBL] [Abstract][Full Text] [Related]
8. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
9. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
[TBL] [Abstract][Full Text] [Related]
10. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
[TBL] [Abstract][Full Text] [Related]
11. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
Davenport ML; Crowe BJ; Travers SH; Rubin K; Ross JL; Fechner PY; Gunther DF; Liu C; Geffner ME; Thrailkill K; Huseman C; Zagar AJ; Quigley CA
J Clin Endocrinol Metab; 2007 Sep; 92(9):3406-16. PubMed ID: 17595258
[TBL] [Abstract][Full Text] [Related]
13. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children.
Scirè G; Del Bianco C; Spadoni GL; Cianfarani S
J Endocrinol Invest; 2008 Feb; 31(2):153-8. PubMed ID: 18362507
[TBL] [Abstract][Full Text] [Related]
15. Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study.
Stevens A; Murray P; Wojcik J; Raelson J; Koledova E; Chatelain P; Clayton P;
Eur J Endocrinol; 2016 Dec; 175(6):633-643. PubMed ID: 27651465
[TBL] [Abstract][Full Text] [Related]
16. A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatment.
Whatmore AJ; Patel L; Clayton PE
Clin Endocrinol (Oxf); 2009 Mar; 70(3):429-34. PubMed ID: 19018778
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
18. Gene expression signatures predict response to therapy with growth hormone.
Stevens A; Murray P; De Leonibus C; Garner T; Koledova E; Ambler G; Kapelari K; Binder G; Maghnie M; Zucchini S; Bashnina E; Skorodok J; Yeste D; Belgorosky A; Siguero JL; Coutant R; Vangsøy-Hansen E; Hagenäs L; Dahlgren J; Deal C; Chatelain P; Clayton P
Pharmacogenomics J; 2021 Oct; 21(5):594-607. PubMed ID: 34045667
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Overall Safety of NutropinAq
Coutant R; Bosch Muñoz J; Dumitrescu CP; Schnabel D; Sert C; Perrot V; Dattani M
Front Endocrinol (Lausanne); 2021; 12():676083. PubMed ID: 34113318
[TBL] [Abstract][Full Text] [Related]
20. GH deficiency status combined with GH receptor polymorphism affects response to GH in children.
Valsesia A; Chatelain P; Stevens A; Peterkova VA; Belgorosky A; Maghnie M; Antoniazzi F; Koledova E; Wojcik J; Farmer P; Destenaves B; Clayton P;
Eur J Endocrinol; 2015 Dec; 173(6):777-89. PubMed ID: 26340968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
